The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity (Q32043227)

5 July 2017

title

The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity (English)

1 reference

5 July 2017

1 reference

1 reference

J G McHutchison

1

1 reference

5 July 2017

J E Ware

2

1 reference

5 July 2017

M S Bayliss

3

1 reference

5 July 2017

S Pianko

4

1 reference

5 July 2017

J K Albrecht

5

1 reference

5 July 2017

S Cort

6

1 reference

5 July 2017

I Yang

7

1 reference

5 July 2017

M P Neary

8

1 reference

5 July 2017

Hepatitis Interventional Therapy Group

9

1 reference

5 July 2017

language of work or name

1 reference

1 January 2001

1 reference

5 July 2017

published in

Journal of Hepatology

1 reference

5 July 2017

volume

34

1 reference

5 July 2017

issue

1

1 reference

5 July 2017

page(s)

140-147

1 reference

Epidemiology of hepatitis C

5 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

Validating the SF-36 health survey questionnaire: new outcome measure for primary care

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

Comparative measurement sensitivity of short and longer health status instruments.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

Patient-based health status measures in outpatient dialysis. Early experiences in developing an outcomes assessment program

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

Methods for assessing condition-specific and generic functional status outcomes after total knee replacement

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

Time-limit tests: estimating their reliability and degree of speeding

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: results from a national survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

The Beaver Dam Health Outcomes Study: initial catalog of health-state quality factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

Differences in the mix of patients among medical specialties and systems of care. Results from the medical outcomes study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

Measuring the functional status and well-being of patients with migraine headache.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

Impaired health-related quality of life in chronic hepatitis C: the how, but not the why.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900026-X

7 January 2021

10.1016/S0168-8278(00)00026-X

Identifiers

DOI

1 reference

5 July 2017

1 reference